Format

Send to

Choose Destination
See comment in PubMed Commons below
Biochem Biophys Res Commun. 2009 Sep 11;387(1):180-5. doi: 10.1016/j.bbrc.2009.06.151. Epub 2009 Jul 4.

Broad neutralizing human monoclonal antibodies against influenza virus from vaccinated healthy donors.

Author information

1
Department of Virology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan.

Abstract

Human monoclonal antibodies (HuMAbs) prepared from patients with viral infections could provide information on human epitopes important for the development of vaccines as well as potential therapeutic applications. Through the fusion of peripheral blood mononuclear cells from a total of five influenza-vaccinated volunteers, with newly developed murine-human chimera fusion partner cells, named SPYMEG, we obtained 10 hybridoma clones stably producing anti-influenza virus antibodies: one for influenza A H1N1, four for influenza A H3N2 and five for influenza B. Surprisingly, most of the HuMAbs showed broad reactivity within subtype and four (two for H3N2 and two for B) showed broad neutralizing ability. Importantly, epitope mapping revealed that the two broad neutralizing antibodies to H3N2 derived from different donors recognized the same epitope located underneath the receptor-binding site of the hemagglutinin globular region that is highly conserved among H3N2 strains.

PMID:
19580789
DOI:
10.1016/j.bbrc.2009.06.151
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center